| Literature DB >> 30182065 |
Guanya Li1,2, Ling Chang1, Guanglei Zhang1, Zehe Song1, Dan Wan2, Chunyan Xie1, Hong Wang3, Zhiyong Fan1.
Abstract
Dibutyryl adenosine cyclophosphate (dbcAMP-Ca), an analog of cyclic adenosine monophosphate (cAMP), plays greater roles in regulating physiological activities and energy metabolism than cAMP. The aim of this study was to investigate the effect of oral administration of dbcAMP-Ca on growth performance and fatty acids metabolism in weaning piglets. A total of 14 early weaning piglets (7 ± 1 d of age, 3.31 ± 0.09 kg, Landrace × Large White × Duroc) were randomly divided into 2 groups: control group and dbcAMP-Ca group, and the piglets received 7 mL of 0.9% NaCl or 1.5 mg dbcAMP-Ca dissolved in 7 mL of 0.9% NaCl per day for 10 d, respectively. The results showed that the average daily gain (ADG) increased by 109.17% (P < 0.05) in the dbcAMP-Ca group compared with the control group. Besides, dbcAMP-Ca significantly decreased blood high density lipoprotein cholesterol (HDLC) concentration (P < 0.05) and significantly increased blood low density lipoprotein cholesterol (LDLC) concentration (P < 0.05) compared with the control group. Further, liver C18:2n6t content significantly increased in dbcAMP-Ca group (P < 0.05) compared with the control group. With the increase of C18:2n6t content, the mRNA expression levels of peroxisome proliferator-activated receptor α (PPARα) and hormone sensitive glycerol three lipase (HSL), of which genes are related to lipid metabolism, were also significantly increased (P < 0.05 or P < 0.01). All of the results indicated that dbcAMP-Ca improved the ADG, which was probably done by regulating fatty acids metabolism in the liver of weaning piglets.Entities:
Keywords: Dibutyryl adenosine cyclophosphate; Early weaning piglets; Growth performance; Hormone sensitive glycerol three lipase; Lipid metabolism; Peroxisome proliferator-activated receptor α
Year: 2018 PMID: 30182065 PMCID: PMC6117734 DOI: 10.1016/j.aninu.2018.06.002
Source DB: PubMed Journal: Anim Nutr ISSN: 2405-6383
Fig. 1The structural formula of dibutyryl adenosine cyclophosphate (dbcAMP-Ca).
Ingredients (%) and nutrient levels (%) of the basal milk (air-dry basis).
| Ingredients | Content | Nutrient levels | Content |
|---|---|---|---|
| Skimmed milk powder | 85.0 | DE, MJ/kg | 14.65 |
| Dried whey | 5.0 | CP | 20.50 |
| Glucose | 2.5 | Ca | 0.70 |
| Plasma proteins | 3.5 | Total P | 0.60 |
| Premix | 4.0 | Lys | 1.45 |
| Total | 100.0 | Met | 0.48 |
| Try | 0.29 |
The premix provided the following for per kg of the basal milk: vitamin A1 500 IU, vitamin D3 200 IU, vitamin E 85 IU, D-pantothenic acid 35 mg, vitamin B2 12 mg, folic acid 1.5 mg, nicotinic acid 35 mg, vitamin B 13.5 mg, vitamin B6 2.5 mg, biotin 0.2 mg, vitamin B12 0.05 mg, copper (as copper sulfate) 15 mg, ferrum (as ferrous sulfate) 100 mg, manganese (as manganese sulfate) 20 mg, iodate (as calcium iodate) 1.0 mg, selenium (as sodium selenite) 0.35 mg, cobalt (as cobalt sulfate) 0.2 mg, and chromium (as chromium picolinate) 0.2 mg.
Primer design parameters.
| Genes | Primers | Sequence (5′ to 3′) | Size, bp |
|---|---|---|---|
| β-actin | Forward | TGCGGGACATCAAGGAGAAG | 216 |
| Forward | GTCCTGCTGAAGCCTAACTC | 206 | |
| Forward | GCTATCATTTGGTGCGGAGAC | 139 | |
| Forward | CCATCAAAACTGCCTTCCTTAG | 118 | |
| Forward | TTCCGCCAAACCTTGAAACT | 100 | |
| Forward | TCCCAGTGCAAGCAGTATG | 211 | |
| Forward | GAAGGGAGAGCTATGGCACC | 130 |
FAS = fatty acid syntheses; PPARα = peroxisome proliferator-activated receptor α; CPT-1α = carnitine palmitoyl transferase 1α; CPT-1β = carnitine palmitoyl transferase 1β; ACCα = acetyl-coA carboxylase α; HSL = hormone sensitive glycerol three lipase.
Fig. 2Effect of dibutyryl adenosine cyclophosphate (dbcAMP-Ca) on the final body weight (A) and average daily gain (B) of weaning piglets (n = 7). * indicates a significant difference (P < 0.05) between the control group and dbcAMP-Ca group.
Blood lipid profiles (mmol/L) of piglets (n = 7).
| Item | Groups | ||
|---|---|---|---|
| Control | dbcAMP-Ca | ||
| TC | 2.47 ± 0.15 | 2.38 ± 0.12 | 0.65 |
| TG | 0.36 ± 0.03 | 0.32 ± 0.04 | 0.56 |
| HDLC | 1.21 ± 0.07∗ | 1.03 ± 0.04 | 0.04 |
| LDLC | 0.80 ± 0.07 | 0.93 ± 0.07∗ | 0.03 |
| T-bil | 20.07 ± 2.06 | 21.39 ± 4.76 | 0.80 |
| D-bil | 2.54 ± 0.50 | 1.97 ± 0.88 | 0.51 |
| TBA | 24.17 ± 6.57 | 14.07 ± 2.69 | 0.18 |
dbcAMP-Ca = dibutyryl adenosine cyclophosphate; TC = total cholesterol; TG = triglyceride; HDLC = high density lipoprotein cholesterol; LDLC = low density lipoprotein cholesterol; T-bil = total bilirubin; D-bil = bilirubin direct; TBA = total bile acid.
* Indicates a significant difference (P < 0.05) between the control group and dbcAMP-Ca group.
Control group: a basal diet; dbcAMP-Ca group: the basal diet supplemented with 1.5 mg/d of dbcAMP-Ca.
Long chain fatty acid content (%) in liver (n = 7).
| Item | Groups | ||
|---|---|---|---|
| Control | dbcAMP-Ca | ||
| C10:0 | 0.02 ± 0.003 | 0.02 ± 0.003 | 0.69 |
| C12:0 | 0.19 ± 0.03 | 0.08 ± 0.03∗ | 0.03 |
| C14:0 | 0.78 ± 0.07 | 0.55 ± 0.27 | 0.09 |
| C15:0 | 0.09 ± 0.01 | 0.07 ± 0.01 | 0.34 |
| C16:0 | 15.34 ± 0.44 | 15.73 ± 0.56 | 0.59 |
| C17:0 | 0.39 ± 0.03 | 0.41 ± 0.03 | 0.75 |
| C18:0 | 21.24 ± 0.61 | 22.21 ± 1.08 | 0.47 |
| C20:0 | 0.04 ± 0.00 | 0.04 ± 0.00 | 0.61 |
| C16:1 | 0.91 ± 0.21 | 0.93 ± 0.37 | 0.94 |
| C17:1 | 0.04 ± 0.01 | 0.03 ± 0.00 | 0.23 |
| C18:1n9t | 0.08 ± 0.02 | 0.07 ± 0.04 | 0.79 |
| C18:1n9c | 17.73 ± 0.98 | 16.77 ± 0.75 | 0.45 |
| C18:2n6t | 0.01 ± 0.003 | 0.013 ± 0.008∗ | 0.04 |
| C18:2n6c | 15.95 ± 0.37 | 16.07 ± 0.67 | 0.88 |
| C18:3n6 | 0.16 ± 0.02 | 0.17 ± 0.02 | 0.76 |
| C18:3n3 | 0.17 ± 0.02 | 0.12 ± 0.05 | 0.14 |
| C20:1 | 0.31 ± 0.03 | 0.28 ± 0.03 | 0.47 |
| C20:3n6 | 2.45 ± 0.20 | 2.53 ± 0.32 | 0.83 |
| C20:4n6 | 17.67 ± 0.37 | 17.36 ± 0.82 | 0.76 |
| C22:6n6 | 6.40 ± 0.30 | 6.49 ± 0.23 | 0.82 |
| SFA | 39.12 ± 0.6 | 40.00 ± 0.70 | 0.28 |
| MUFA | 17.82 ± 0.98 | 16.85 ± 0.76 | 0.44 |
| PUFA | 80.52 ± 0.86 | 77.48 ± 1.11 | 0.08 |
* Indicates a significant difference (P < 0.05) between the control group and dbcAMP-Ca group.
Control group: a basal diet; dbcAMP-Ca group: the basal diet supplemented with 1.5 mg/d of dbcAMP-Ca.
Fig. 3Effect of dibutyryl adenosine cyclophosphate (dbcAMP-Ca) on the mRNA expression levels of lipid metabolism related genes in liver (n = 7). PPARα = peroxisome proliferator-activated receptor α; FAS = fatty acid syntheses; CPT-1α = carnitine palmitoyl transferase 1α; CPT-1β = carnitine palmitoyl transferase 1β; ACCα = acetyl-coA carboxylase α; HSL = hormone sensitive glycerol three lipase. * and ** indicate significant difference (P < 0.05) and extreamly significant difference (P < 0.01) between the control group and dbcAMP-Ca group, respectively.